23.07.2020 22:41:06
|
Edwards Lifesciences Raises 2020 Adj. EPS Guidance; Reiterates Sales Outlook
(RTTNews) - Edwards Lifesciences Corp. (EW) said the company now expects full-year 2020 adjusted earnings per share of $1.75 to $1.95 on a post-split basis, versus previous guidance of $1.58 to $1.75, or on a pre-split basis, $4.75 to $5.25. Overall, 2020 sales guidance continues to be $4.0 to $4.5 billion.
For the third quarter, the company projects total sales to be between $1.0 and $1.2 billion. Edwards projects sales in the third quarter to return to 2019 levels, and for sales to start growing again in the fourth quarter.
Second quarter adjusted earnings per share decreased 26% to $0.34. On average, 21 analysts polled by Thomson Reuters expected the company to report profit per share of $0.17, for the quarter. Analysts' estimates typically exclude special items.
Second quarter sales were $925 million, a decrease of 15% over the prior year, or down 14% on an underlying basis. Analysts expected revenue of $797.53 million for the quarter. For the quarter, the company reported global TAVR sales of $594 million, a decrease of 12% over last year, or down 11% on an underlying basis.
Shares of Edwards Lifesciences were up 5% after hours.
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Edwards Lifesciences Corp.mehr Nachrichten
18.12.24 |
S&P 500-Papier Edwards Lifesciences-Aktie: So viel hätten Anleger mit einem Investment in Edwards Lifesciences von vor einem Jahr verloren (finanzen.at) | |
11.12.24 |
S&P 500-Wert Edwards Lifesciences-Aktie: So viel Gewinn hätte ein Investment in Edwards Lifesciences von vor 10 Jahren eingefahren (finanzen.at) | |
10.12.24 |
Optimismus in New York: Anleger lassen S&P 500 zum Handelsstart steigen (finanzen.at) | |
04.12.24 |
Börse New York: S&P 500 präsentiert sich letztendlich fester (finanzen.at) | |
04.12.24 |
Gute Stimmung in New York: S&P 500 verbucht Zuschläge (finanzen.at) | |
04.12.24 |
Pluszeichen in New York: S&P 500 notiert am Mittwochmittag im Plus (finanzen.at) | |
04.12.24 |
Freundlicher Handel in New York: S&P 500 zum Handelsstart mit grünem Vorzeichen (finanzen.at) | |
04.12.24 |
S&P 500-Papier Edwards Lifesciences-Aktie: So viel hätten Anleger an einem Edwards Lifesciences-Investment von vor 5 Jahren verloren (finanzen.at) |